New 52 Week Low Today

NLS Pharmaceutics Equity Warrant Exp 25th Sep 2025 NLSPW:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 01/21/22 EST
0.31quote price arrow down-0.0137 (-4.2323%)
Volume
15,638
52 week range
0.27 - 2.18
Loading...
  • Open0.3325
  • Day High0.3325
  • Day Low0.2701
  • Prev Close0.3237
  • 52 Week High2.18
  • 52 Week High Date03/12/21
  • 52 Week Low0.27
  • 52 Week Low Date01/21/22

Key Stats

  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.3325
  • Day High0.3325
  • Day Low0.2701
  • Prev Close0.3237
  • 52 Week High2.18
  • 52 Week High Date03/12/21
  • 52 Week Low0.27
  • 52 Week Low Date01/21/22
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On NLS Pharmaceutics Equity Warrant Exp 25th Sep 2025

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
NLS Pharmaceutics AG, formerly NLS 1 Pharma AG, is a Switzerland-based company that operates as a biopharmaceutical company. The Company focuses on development of medicines for neurobehavioral and neurocognitive disorders treatment. The Company serves customers worldwide.
Ronald Hafner
Independent Chairman of the Board
Alexander Zwyer
Chief Executive Officer, Director
Silvia Panigone Ph.D.
Chief Operating Officer
Subhasis Roy
Interim Chief Financial Officer
Address
Alter Postplatz 2
Stans
6370
Switzerland